A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/505 (2006.01) A61K 31/00 (2006.01) A61K 31/425 (2006.01) A61K 31/44 (2006.01)
Patent
CA 2182986
A method for the treatment and/or prophylaxis of renal diseases including diabetic nephropathy, glomerulonephritis, glomerular sclerosis, nephrotic syndrome, hypertensive nephrosclerosis and end stage renal disease, and microalbuminuria which method comprises the administration of an effective, non-toxic amount of an insulin sensitiser to a human or non-human mammal in need thereof.
L'invention se rapporte à un procédé de traitement et/ou à la prophylaxie des insuffisances rénales, y compris la néphropathie diabétique, la glomérulonéphrite, la glomérulosclérose, le syndrome néphrotique, la néphrosclérose hypertensive et l'insuffisance rénale au stade ultime ainsi que la microalbuminurie. Ce procédé consiste à administrer une dose efficace, non-toxique, d'un sensibilisateur à l'insuline à un être humain ou à un mammifère nécessitant ce traitement.
Gowling Lafleur Henderson Llp
Smithkline Beecham P.l.c.
LandOfFree
Use of insulin sensitisers for treating renal diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of insulin sensitisers for treating renal diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of insulin sensitisers for treating renal diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1571313